Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer

Clinical trial NCT01279291 · TERMINATED

Trial details

NCT number: NCT01279291
Sponsor: Kyowa Kirin Co., Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasms Ovarian Neoplasms Fallopian Tube Neoplasms Primary Peritoneal Neoplasm

Start date: 2011-01-01
Primary completion: 2012-11-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.